Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma

Cancer Science

Volumn 97, Issue 2, 2006, Pages 163-166

  Yoshino, Tadashi ^a   Nakamura, Shigeo ^b   Matsuno, Yoshihiro ^c   Ochiai, Atsushi ^d   Yokoi, Takio ^e   Kitadai, Yasuhiko ^f   Suzumiya, Junji ^g   Tobinai, Kensei ^c   Kobayashi, Yukio ^c   Oda, Ichiro ^c   Mera, Kiyomi ^d   Ohtsu, Atsushi ^d   Ishikura, Satoshi ^d  

^a OKAYAMA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f HIROSHIMA UNIVERSITY   (Japan)

^g FUKUOKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BRAIN METASTASIS; CANCER GROWTH; CANCER RECURRENCE; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; LYMPH NODE METASTASIS; LYMPHOMA CELL; MALE; PREDICTION; PRIORITY JOURNAL; STOMACH LYMPHOMA; TREATMENT FAILURE; VIRUS INFECTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CEREBELLAR NEOPLASMS; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDNISONE; PROGNOSIS; RADIATION TOLERANCE; REMISSION INDUCTION; RNA, VIRAL; STOMACH NEOPLASMS; SURVIVAL RATE; VINCRISTINE;

EID: 33644890755     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00155.x     Document Type: Article

References (17)

1. Wotherspoon AC. A critical review of the effect of Helicobacter pylori eradication on gastric MALT lymphoma. Curr Gastroenterol Rep 2000; 2: 494-8.
2. Bozzetti F, Audisio RA, Giardini R, Gennari L. Role of surgery in patients with primary non-Hodgkin's lymphoma of the stomach: An old problem revisited. Br J Surg 1993; 80: 1101-6.
3. Ruskone-Fourmestraux A, Aegerter P, Delmer A et al. Primary digestive tract lymphoma: A prospective multicentric study of 91 patients. Groupe d'Etude des Lymphomes Digestifs. Gastroenterol 1993; 105: 1662-71.
4. Bartlett DL, Karpeh MS Jr, Filippa DA, Brennan MF. Long-term follow-up after curative surgery for early gastric lymphoma. Ann Surg 1996; 223: 53-62.
5. Vaillant JC, Ruskone-Fourmestraux A, Aegerter P et al. Management and long-term results of surgery for localized gastric lymphomas. Am J Surg 2000; 179: 216-22.
6. Miller TP, Dahlberg S, Cassady JR et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 1998; 339: 21-6.
7. Ishikura S, Tobinai K, Ohtsu A, Nakamura S et al. Japanese multicenter phase II study of CHOP followed by radiotherapy in stage I-II, diffuse large B-cell lymphoma of the stomach. Cancer Sci 2005 ; 96: 349-52.
8. Jaffe ES, Harris NL, Stein H et al. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2001.
9. Rohatiner A, d'Amore F, Coiffier B et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397-400.
10. Hui PK, Tokunaga M, Chan WY, Ng CS, Chow J, Lee JC. Epstein-Barr virus-associated gastric lymphoma in Hong Kong Chinese. Hum Pathol 1994; 25: 947-52.
11. Liu Q, Ohshima K, Masuda Y, Kikuchi M. Detection of the Epstein-Barr virus in primary gastric lymphoma by in situ hybridization. Pathol Int 1995; 45: 131- 6.
12. Lee SS, Jang JJ, Cho KJ, Khang SK, Kim CW. Epstein-Barr virus-associated primary gastrointestinal lymphoma in non-immunocompromised patients in Korea. Histopathol 1997; 30: 234-42.
13. Yang WI, Cho MS, Tomita Y, Ohsawa M, Aozasa K. Epstein-Barr virus and gastrointestinal lymphomas in Korea. Yonsei Med J 1998; 39: 268-76.
14. Chan WY, Chan EK, Chow JH. Epstein-Barr virus-associated gastric lymphomas are distinct from mucosa-associated lymphoid tissue-type lymphomas: Genetic abnormalities of p53 gene. Diagn Mol Pathol 2001; 10: 153-60.
15. Koch P, del Valle F, Berdel WE et al. Primary gastrointestinal non-Hodgkin's lymphoma. II. Combined surgical and conservative or conservative management only in localized gastric lymphoma - results of the prospective German Multicenter Study GIT NHL 01/92. J Clin Oncol 2001 15: 3874-83.
16. Jarrett RF, Stark GL, White J et al. Impact of tumour Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classical Hodgkin lymphoma: A population-based study. Blood 2005; 106: 2444-51: [Epub June 7 ahead of print].
17. Oyama T, Ichimura K, Suzuki R et al. Senile EBV+ B-cell lymphoproliferative disorders: A clinicopathologic study of 22 patients. Am J Surg Pathol 2003; 27: 16-26.